At the moment, Rybelsus isnt licensed as a weight management treatment, but as it uses semaglutide as its active ingredient, this may be a development we see in the future
If and when retatrutide does get FDA approval, itll be especially important to monitor the drug while long-term safety and real patient side effects are still being established
Cagrilintide is being developed by Novo Nordisk, the same company that makes semaglutide (Ozempic, Wegovy, Rybelsus)
The primary reason people microdose GLP-1s is to make their medication last longer and, therefore, save money
Compounded Intranasal PT-141: Clinical Considerations Formulation and Dosing Standard Intranasal Formulation: Typically compounded at concentrations of 1 mg/ml to 10 mg/ml